ZymoGenetics (ZGEN) Reports Q3 Loss of $0.17
ZymoGenetics Inc. (NASDAQ: ZGEN) reports Q3 loss of $0.17, 3 cents better than the analyst estimate of ($0.20). Revenue for the quarter was $27.5 million, which compares to the estimate of $31.52 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Toro Co. (TTC) Tops Q1 EPS by 13c; Guides FY12 EPS Above Views; to Split Stock
- Semtech Corp (SMTC) Misses Q1 EPS by 4c; Guides Q2
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
